Press Room

Post March 19, 2012

The huge potential of GLP-1 receptor agonists in the diabetes market opens opportunities for technology providers and Big Pharma

Post November 24, 2011

Blockbuster Drugs 2010: small molecules still dominating, but biologics strongly emerging

Post October 26, 2011

Fierce Competition Requires Precision in Meeting the Needs of the Coagulation Factor Market

Post September 19, 2011

Antibody-Drug Conjugates 2011 - real breakthrough still to come

Post March 07, 2011

Biologics Sales in 2010 exceeded US$ 100 bln

La Merie Publishing  · Mittelstrasse 11 · 70180 Stuttgart · Germany · T +49-1570-3544 127 ·  F +49-3212-1267 572 · publishing@lamerie.com